Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 Pandemic

Ege University

Status

Completed

Conditions

Fibromyalgia

Coronavirus Disease 2019 Pandemic

Treatments

Other: Questionnaires and physical examination

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05410808

21-1T/52

Details and patient eligibility

About

Fibromyalgia patients and controls living in the same household will be evaluated for levels of resilience, covid-19 related anxiety, coronavirus disease 2019 related obsession, quality of life and pain and comparisons and correlation analyses will be carried out.

Full description

Fibromyalgia is a generalized pain condition that is accompanied by sleep disturbances, anxiety, depression and somatic symptoms. During Coronavirus disease 2019 pandemic, fibromyalgia patients as well as the general population have increased anxiety levels. This study was planned to evaluate fibromyalgia patients' levels of coronavirus disease 2019 related resilience, anxiety, obsession levels about coronavirus disease 2019, quality of life and pain levels and compare them with healthy controls living in the same household.

Enrollment

78 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Having a diagnosis of fibromyalgia according to the American college of rheumatology 2016 classification criteria
Older than 18 years of age

Exclusion criteria

Illiteracy
A history of coronavirus disease 2019 infection in the last month
Change in medication to treat fibromyalgia in the last 3 months
Living alone (lack of a control subject)
Severe neurological or psychiatric disorder that might hinder subjects' ability to answer the study questions